Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

BIO CEO & Investor Conference

13-Jan-2016
Finance | Pharmaceutical

8 - 9 February 2016, Conference, The Waldorf Astoria New York, NY, US

8 - 9 February 2016

Conference

The Waldorf Astoria New York, NY, US


Now in its 18th year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies.

Organiser: BIO (Biotechnology Innovation Organization)

www.bio.org

Related Content

SCHOTT Pharma reveals strong financial performance in fiscal year 2022
SCHOTT Pharma reveals strong financial performance in fiscal year 2022
Brenntag signs multi-year partnership with Workday Human Capital
Brenntag signs multi-year partnership with Workday Human Capital
How early stage life sciences companies can improve the odds of attracting funding
How early stage life sciences companies can improve the odds of attracting funding
InDevR raises $9m in series B financing
InDevR raises $9m in series B financing
Sun Pharma enters definitive financial agreement with Concert
Sun Pharma enters definitive financial agreement with Concert
Investment, outsourcing and globalisation: key trends for 2023
Investment, outsourcing and globalisation: key trends for 2023
Sanofi increases evergreen fund to $750m
Sanofi increases evergreen fund to $750m
Argonaut expands with capital investment
Argonaut expands with capital investment
Get ahead of the curve in 2023 with a subscription
Get ahead of the curve in 2023 with a subscription
Novo invests $40m in proteomics technology company
Novo invests $40m in proteomics technology company
Lilly and ProQR to expand RNA editing collaboration
Lilly and ProQR to expand RNA editing collaboration
Scorpion Biological Services becomes Scorpius BioManufacturing to reflect expansion
Scorpion Biological Services becomes Scorpius BioManufacturing to reflect expansion
Biocair reports "significant growth" for 2022
Biocair reports "significant growth" for 2022
How soon is too soon to consider market access strategies for my specialty drug?
How soon is too soon to consider market access strategies for my specialty drug?
India pharma forecast record growth for 2023
India pharma forecast record growth for 2023
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company